Search

Glitab

Glitab

gliclazide

Manufacturer:

Lloyd

Distributor:

Littman
Concise Prescribing Info
Contents
Gliclazide
Dosage/Direction for Use
Initially, 40 mg daily, may increase up to 320 mg daily. Doses >160 mg should be given in divided doses.
Click to view Glitab detailed prescribing information
Overdosage
View Glitab overdosage for action to be taken in the event of an overdose.
Administration
Should be taken with food.
Contraindications
Hypersensitivity. Diabetes complicated w/ acidosis, ketosis or coma. Juvenile onset diabetes & unstable or brittle diabetes. Severe renal & liver disease.
Click to view Glitab detailed prescribing information
Special Precautions
Hepatic & renal impairment. Hypoglycemia may occur. Pregnancy & lactation.
Click to view Glitab detailed prescribing information
Adverse Reactions
Nausea, headache, rashes & GI disturbances.
Click to view Glitab detailed prescribing information
Drug Interactions
Potentiation w/ phenylbutazone, β-adrenoreceptor blocking agents, MAOIs, ketoconazole & miconazole. Diminution of hypoglycemic action w/ thiazide diuretics, corticosteroids & estrogens.
Click to view Glitab detailed prescribing information
Storage
View Glitab storage conditions for details to ensure optimal shelf-life.
Description
View Glitab description for details of the chemical structure and excipients (inactive components).
Action
View Glitab mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Antidiabetic Agents
ATC Classification
A10BB09 - gliclazide ; Belongs to the class of sulfonylureas. Used in the treatment of diabetes.
Presentation/Packing
Form
Glitab MR tab 30 mg
Packing/Price
100's (P358/box)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in